LeMaitre Vascular Pre-Tax Profit Margin 2010-2025 | LMAT
LeMaitre Vascular pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| LeMaitre Vascular Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.23B | $0.06B | 25.99% |
| 2024-12-31 | $0.22B | $0.06B | 26.36% |
| 2024-09-30 | $0.21B | $0.06B | 25.82% |
| 2024-06-30 | $0.21B | $0.05B | 24.39% |
| 2024-03-31 | $0.20B | $0.04B | 22.11% |
| 2023-12-31 | $0.19B | $0.04B | 20.21% |
| 2023-09-30 | $0.19B | $0.04B | 19.46% |
| 2023-06-30 | $0.18B | $0.03B | 18.08% |
| 2023-03-31 | $0.17B | $0.03B | 16.57% |
| 2022-12-31 | $0.16B | $0.03B | 17.28% |
| 2022-09-30 | $0.16B | $0.03B | 17.39% |
| 2022-06-30 | $0.16B | $0.03B | 18.75% |
| 2022-03-31 | $0.16B | $0.03B | 21.38% |
| 2021-12-31 | $0.16B | $0.03B | 21.29% |
| 2021-09-30 | $0.15B | $0.03B | 22.22% |
| 2021-06-30 | $0.15B | $0.04B | 23.18% |
| 2021-03-31 | $0.14B | $0.03B | 22.22% |
| 2020-12-31 | $0.13B | $0.03B | 20.77% |
| 2020-09-30 | $0.12B | $0.02B | 18.85% |
| 2020-06-30 | $0.12B | $0.02B | 17.39% |
| 2020-03-31 | $0.12B | $0.02B | 17.65% |
| 2019-12-31 | $0.12B | $0.02B | 18.97% |
| 2019-09-30 | $0.11B | $0.02B | 21.05% |
| 2019-06-30 | $0.11B | $0.02B | 21.10% |
| 2019-03-31 | $0.11B | $0.03B | 27.10% |
| 2018-12-31 | $0.11B | $0.03B | 27.62% |
| 2018-09-30 | $0.10B | $0.03B | 27.18% |
| 2018-06-30 | $0.10B | $0.03B | 26.92% |
| 2018-03-31 | $0.10B | $0.02B | 20.39% |
| 2017-12-31 | $0.10B | $0.02B | 19.80% |
| 2017-09-30 | $0.10B | $0.02B | 18.37% |
| 2017-06-30 | $0.10B | $0.02B | 18.75% |
| 2017-03-31 | $0.09B | $0.02B | 18.48% |
| 2016-12-31 | $0.09B | $0.02B | 18.18% |
| 2016-09-30 | $0.09B | $0.02B | 17.65% |
| 2016-06-30 | $0.08B | $0.01B | 16.05% |
| 2016-03-31 | $0.08B | $0.01B | 15.19% |
| 2015-12-31 | $0.08B | $0.01B | 14.10% |
| 2015-09-30 | $0.08B | $0.01B | 14.29% |
| 2015-06-30 | $0.08B | $0.01B | 13.16% |
| 2015-03-31 | $0.07B | $0.01B | 12.16% |
| 2014-12-31 | $0.07B | $0.01B | 9.72% |
| 2014-09-30 | $0.07B | $0.01B | 7.04% |
| 2014-06-30 | $0.07B | $0.00B | 5.88% |
| 2014-03-31 | $0.07B | $0.00B | 4.55% |
| 2013-12-31 | $0.06B | $0.00B | 6.25% |
| 2013-09-30 | $0.06B | $0.00B | 6.56% |
| 2013-06-30 | $0.06B | $0.00B | 6.67% |
| 2013-03-31 | $0.06B | $0.00B | 6.90% |
| 2012-12-31 | $0.06B | $0.00B | 7.02% |
| 2012-09-30 | $0.06B | $0.00B | 7.27% |
| 2012-06-30 | $0.06B | $0.01B | 8.93% |
| 2012-03-31 | $0.06B | $0.01B | 8.77% |
| 2011-12-31 | $0.06B | $0.00B | 6.90% |
| 2011-09-30 | $0.06B | $0.00B | 3.39% |
| 2011-06-30 | $0.06B | $0.00B | 3.45% |
| 2011-03-31 | $0.06B | $0.00B | 5.26% |
| 2010-12-31 | $0.06B | $0.00B | 7.14% |
| 2010-09-30 | $0.06B | $0.01B | 10.71% |
| 2010-06-30 | $0.06B | $0.01B | 9.09% |
| 2010-03-31 | $0.05B | $0.00B | 7.41% |
| 2009-12-31 | $0.05B | $0.00B | 1.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.778B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |